7-(3-(2-(cyclopropylmethyl)-3-methoxy-4-((methylamino)carbonyl)phenoxy)propoxy)-3,4-dihydro-8-propyl-2h-1-benzopyran-2-propanoic acid has been researched along with Edema in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baron, DA; Fretland, DJ; Gokhale, R; Mathur, L; Paulson, SK; Stolzenbach, J | 1 |
1 other study(ies) available for 7-(3-(2-(cyclopropylmethyl)-3-methoxy-4-((methylamino)carbonyl)phenoxy)propoxy)-3,4-dihydro-8-propyl-2h-1-benzopyran-2-propanoic acid and Edema
Article | Year |
---|---|
Dermal inflammation in primates, mice, and guinea pigs: attenuation by second-generation leukotriene B4 receptor antagonist, SC-53228.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Benzopyrans; Disease Models, Animal; Drug Eruptions; Drug Evaluation, Preclinical; Ear, External; Edema; Female; Gels; Guinea Pigs; Humans; Male; Mice; Peroxidase; Psoriasis; Receptors, Leukotriene B4; Tetradecanoylphorbol Acetate | 1995 |